10.12.2023 - By American Academy of Neurology
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPub.org/Podcast for associated article links.